Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Cash & Equivalents (2016 - 2025)

Codexis (CDXS) has 16 years of Cash & Equivalents data on record, last reported at $50.8 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 163.67% year-over-year to $50.8 million; the TTM value through Dec 2025 reached $50.8 million, up 163.67%, while the annual FY2025 figure was $50.8 million, 163.67% up from the prior year.
  • Cash & Equivalents reached $50.8 million in Q4 2025 per CDXS's latest filing, up from $25.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $139.7 million in Q1 2021 and bottomed at $18.3 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $75.1 million, with a median of $82.3 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: plummeted 79.81% in 2024, then skyrocketed 163.67% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $116.8 million in 2021, then decreased by 2.41% to $114.0 million in 2022, then crashed by 42.87% to $65.1 million in 2023, then crashed by 70.42% to $19.3 million in 2024, then surged by 163.67% to $50.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $50.8 million in Q4 2025, $25.4 million in Q3 2025, and $26.8 million in Q2 2025.